Mark Faupel

Nestor, Inc. through its wholly owned subsidiary, Nestor Traffic Systems, Inc. provides innovative video based traffic safety and enforcement systems to state and local governments. The company's principal product, CrossingGuard incorporates patented image processing technology into an intelligent turnkey solution that predicts and records the occurrence of a red light violation and manages the entire process of issuing and processing a citation. It was founded in 1975 and is headquartered in Providence, RI.

Moore Capital Management LP (Moore Capital) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Louis Bacon in 1989 and is a subsidiary of Moore Capital Advisors LLC, ultimately held by MCM Group Holdings, Inc. Moore Capital provides investment management services on a discretionary basis to US and non-US privately-offered investment funds sponsored by Moore Group.

DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease. Because of their unique immune modulating and anti-inflammatory properties, these therapies may potentially benefit people with type 1 and type 2 diabetes and represent a total available market opportunity of approximately $13 billion. The Company's lead compound, Lisofylline (LSF), has had an excellent safety profile in clinical trials to date. LSF works at the cellular level by improving the function of insulin producing islet cells and protecting them from damage and premature death caused when the body's immune system turns on itself. This autoimmune action is the cause of type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA), which combined affect approximately three million people in the U.S. About three million people with type 2 diabetes use insulin due to diminished insulin production and an increasing resistance to insulin. A primary focus of DiaKine's research and development is on its next generation of orally bioavailable immune modulators which have an improved spectrum of action to LSF. Two such compounds, DT22669 and DT23552, have been identified for further development and are examples of the extensive library of analogs and new structures in its patent portfolio that await discovery for future indications.

Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA.

Medfusion, Inc. engages in the provision of patient engagement platform. Its solutions includes patient portal, self-scheduling, medfusion APIs, premier services, medfusion pay, and medfusion plus. The firm operates as a web and mobile-based platform that includes payment services and personal health records for patients. The company was founded by Stephen N. Malik and Michael Hardage in 2000 and is headquartered in Cary, NC.

Eisner LLP provides auditing, accounting and tax services, as well as corporate finance, legal support, information technology and other professional services to its clients. It provide financial services, not-for-profit, law firms, sports, media & entertainment and real estate. The company is headquartered in New York, NY.

State Compensation Insurance Fund provides workers compensation insurance, claims management, coordinated care plans and loss control services. The company operates throughout the state of California. It was founded in 1914 and is headquartered in San Francisco, CA.

Part of Giga-tronics, Inc., Ultracision, Inc. makes robotic equipment for the handling and inspection of silicon wafers. The company is based in Santa Clara, CA. The company was founded by Thomas W. Davison, Chuck G. Hadley. Ultracision was acquired by Giga-tronics, Inc. on December 10, 1997 for $5.24 million.

Active Protective Technologies, Inc. develops medical technology solutions. It provides a smartbelt that can determine a human fall, and deploys airbags to protect the hips of older adults. The device also has all functionality of medical alert pendants, and will therefore wirelessly alert caregivers. The company was founded by Drew Lakatos and Robert F. Buckman and is headquartered in Philadelphia, PA.

Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA.

SNTech Co. Ltd. develops, manufactures, and sells food additives. It also offers health and care products, including living preservatives, cosmetic preservatives, and basic materials; and drug products comprising excipients, thickeners and coatings. The company was founded by James Jeung and Shannon Bard in 2003 and is headquartered in Seongam, South Korea.

Elevate Ventures, Inc (Elevate Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Indianapolis.